Journey Medical Corporation (DERM) Ownership
DERM ownership summary
as of October 18, 2026- Institutions
- 47.9% of shares outstanding
- Insiders
- 31.75% of shares outstanding
- Shares outstanding
- 22.2M
- Float
- 15.6M shares available to trade
- Short interest
- 19.28% 3.1M shares short
- Days to cover
- 17.61 short interest up 4.4% vs prior month
- Institutions 47.94%
- Insiders 31.75%
- Other investors 20.30%
DERM top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Wasatch Advisors LP | 10.13% | 2.9M | $14.2M | +725,560 (+34.0%) | June 30, 2026 |
| 2 | TANG CAPITAL MANAGEMENT LLC | 5.70% | 1.6M | $8.0M | — | June 30, 2026 |
| 3 | Vanguard Capital Management, LLC | 2.39% | 675K | $3.4M | −406,895 (−37.6%) | June 30, 2026 |
| 4 | Punch & Associates Inv Mgmt Inc | 1.90% | 536K | $2.7M | +536,000 (0.0%) | June 30, 2026 |
| 5 | Pale Fire Capital SE | 1.87% | 529K | $2.6M | +46,597 (+9.7%) | June 30, 2026 |
| 6 | Opaleye Management Inc | 1.24% | 350K | $1.7M | −610,000 (−63.5%) | June 30, 2026 |
| 7 | Summit Financial LLC | 1.23% | 347K | $1.7M | −33,059 (−8.7%) | June 30, 2026 |
| 8 | Jane Street Group LLC | 1.13% | 320K | $1.6M | +320,021 (0.0%) | June 30, 2026 |
| 9 | Diametric Capital, LP | 1.05% | 296K | $1.5M | +99,251 (+50.5%) | June 30, 2026 |
| 10 | Ikarian Capital, LLC | 0.89% | 251K | $1.2M | — | June 30, 2026 |
| 11 | Renaissance Technologies Corp | 0.81% | 230K | $1.1M | −12,800 (−5.3%) | June 30, 2026 |
| 12 | Geode Capital Management, LLC | 0.77% | 216K | $1.1M | −247,198 (−53.4%) | June 30, 2026 |
| 13 | American Financial Group Inc | 0.64% | 180K | $893,700 | — | June 30, 2026 |
| 14 | Trexquant Investment LP | 0.61% | 171K | $850,693 | +143,242 (+509.8%) | June 30, 2026 |
| 15 | Marshall Wace Asset Management Ltd | 0.50% | 140K | $694,320 | +139,843 (0.0%) | June 30, 2026 |
| 16 | J. Goldman & Co LP | 0.49% | 138K | $683,105 | −362,604 (−72.5%) | June 30, 2026 |
| 17 | Millennium Management LLC | 0.39% | 110K | $546,229 | −273,051 (−71.3%) | June 30, 2026 |
| 18 | BlackRock Inc | 0.36% | 101K | $501,371 | −871,881 (−89.6%) | June 30, 2026 |
| 19 | XTX Topco Ltd | 0.36% | 101K | $501,083 | +71,559 (+243.7%) | June 30, 2026 |
| 20 | Vanguard Fiduciary Trust Co | 0.34% | 95K | $470,329 | −42,977 (−31.2%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 8 holders added 2.1M shares and 9 cut 2.9M.
DERM top mutual fund and ETF holders
17 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Wasatch Micro Cap | 4.91% | 1.4M | $6.9M | +566,255 (+69.2%) | June 30, 2026 |
| 2 | Wasatch Micro Cap Value | 2.89% | 814K | $4.0M | +93,972 (+13.0%) | June 30, 2026 |
| 3 | Vanguard MStar Total Stk Mkt Idx Invest | 1.67% | 470K | $2.3M | — | August 31, 2026 |
| 4 | First Eagle Small Cap Opportunity I | 0.89% | 252K | $1.3M | +252,438 (0.0%) | August 31, 2026 |
| 5 | Fidelity Extended Market Index | 0.29% | 83K | $413,113 | +2,302 (+2.8%) | August 31, 2026 |
| 6 | iShares Micro-Cap ETF | 0.16% | 45K | $221,275 | −307 (−0.7%) | September 30, 2026 |
| 7 | Fidelity Total Market Index | 0.15% | 41K | $205,293 | — | August 31, 2026 |
| 8 | Fidelity Series Total Market Index | 0.09% | 25K | $126,419 | −7,072 (−21.7%) | August 31, 2026 |
| 9 | First Eagle US Small Cap Opp I-UC | 0.08% | 23K | $115,019 | +23,166 (0.0%) | August 31, 2026 |
| 10 | Invesco NASDAQ Future Gen 200 ETF | 0.06% | 16K | $80,368 | — | September 30, 2026 |
| 11 | Fidelity Nasdaq Composite Index | 0.05% | 14K | $69,828 | — | August 31, 2026 |
| 12 | Vanguard Balanced Index Inv | 0.04% | 10K | $51,725 | — | August 31, 2026 |
| 13 | Vanguard MStar Inst Ttl StkMktIdxInstlPl | 0.03% | 7,375 | $36,617 | — | August 31, 2026 |
| 14 | Vanguard U.S. Eq Idx £ Acc | 0.02% | 4,642 | $23,048 | — | August 31, 2026 |
| 15 | 1290 VT Micro Cap K | 0.01% | 3,380 | $16,782 | — | August 31, 2026 |
| 16 | DFA US Micro Cap I | 0.01% | 3,125 | $15,516 | — | August 31, 2026 |
| 17 | Victory Extended Market Index | 0.01% | 1,559 | $7,740 | −661 (−29.8%) | June 30, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
DERM insider transactions
latest 2| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2025-05-02 | Claude Maraoui | Sell | $6.84 | 4,834 | $33,065 |
| 2025-05-02 | Ramsey Alloush | Sell | $6.84 | 2,857 | $19,542 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
DERM shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns DERM
Institutional investors own 47.9% of Journey Medical's shares and insiders 31.75%. The largest holder is Wasatch Advisors LP with 10.13% of the shares (2.9M), as of June 30, 2026. Among the top 20 institutions, 8 added shares and 9 reduced their stake in the latest filings. Short interest is 19.28% of the float, or 17.61 days of average trading volume.
Related: DERM analyst forecast, DERM key metrics. See the DERM stock overview for the latest quote and news.
DERM ownership FAQ
Who owns the most Journey Medical stock?
The largest shareholders of Journey Medical are Wasatch Advisors LP (10.13%), TANG CAPITAL MANAGEMENT LLC (5.70%), Vanguard Capital Management, LLC (2.39%), Punch & Associates Inv Mgmt Inc (1.90%), Pale Fire Capital SE (1.87%).
What percentage of Journey Medical is owned by institutions?
Institutions hold 47.9% of Journey Medical's shares outstanding; insiders hold 31.75%.
Which funds own Journey Medical?
The largest fund holders of Journey Medical are Wasatch Micro Cap (4.91%), Wasatch Micro Cap Value (2.89%), Vanguard MStar Total Stk Mkt Idx Invest (1.67%), First Eagle Small Cap Opportunity I (0.89%), Fidelity Extended Market Index (0.29%).
What is Journey Medical's short interest?
3.1M shares of Journey Medical were sold short, 19.28% of the float; at the average daily volume it would take 17.61 days to cover.
Are insiders buying or selling Journey Medical?
Of the latest 2 reported insider transactions in Journey Medical (since May 2, 2025), 0 were purchases and 2 were sales.
How many shares of Journey Medical are outstanding?
Journey Medical has 22.2M shares outstanding, of which 15.6M are in the public float.